首页> 外国专利> MEANS FOR CORRECTION OF PATHOLOGICAL CONDITIONS OF CELLS OF ORGANS AND TISSUES AND/OR HUMAN ORGANS AND TISSUES, BASED ON THE GENE OF GPX3, RELATED TO OXIDATIVE STRESS, METHOD OF OBTAINING AND USING

MEANS FOR CORRECTION OF PATHOLOGICAL CONDITIONS OF CELLS OF ORGANS AND TISSUES AND/OR HUMAN ORGANS AND TISSUES, BASED ON THE GENE OF GPX3, RELATED TO OXIDATIVE STRESS, METHOD OF OBTAINING AND USING

机译:基于GPX3基因的与氧化应激有关的纠正器官和组织和/或人类器官和组织的细胞病理状况的方法,获取和使用方法

摘要

FIELD: medicine.;SUBSTANCE: group of inventions relates to medicine and relates to a means for correcting the pathological conditions of cells of organs and tissues and/or human organs and tissues based on the GPX3 gene associated with oxidative stress, where the cells of organs and tissues are selected from cells of fibroblasts, keratocytes and epithelial cells of the eye, chondroblasts; organs and tissues are selected from the skin, the mucous membrane of the human mouth or the human muscle tissue, which is a complex of biologically active gene therapy substances, each of a complex of biologically active gene therapeutic substances is a genetic construct based on a vector plasmid comprising the cDNA portion of the GPX3 gene and also containing regulatory elements that transcribe this sequence in eukaryotic cells, namely in cells of human organs and tissues, in combination with or without a transport molecule. Group of inventions also relates to a method for producing said agent for correcting the pathological conditions of cells of organs and tissues and/or human organs and tissues based on the GPX3 gene associated with oxidative stress; a method of using said agent for correcting the pathological conditions of cells of organs and tissues and/or human organs and tissues based on the GPX3 gene associated with a quantitative reduction in the GPX3 protein.;EFFECT: group of inventions provides a high and stable level of the target protein in the cells.;5 cl, 18 ex, 20 dwg
机译:发明领域本发明涉及药物,并且涉及一种用于基于与氧化应激相关的GPX3基因校正器官和组织和/或人体器官和组织的细胞的病理状况的手段,其中器官和组织选自成纤维细胞,角膜细胞和眼睛的上皮细胞,成软骨细胞。器官和组织选自皮肤,人嘴的粘膜或人类肌肉组织,其是生物活性基因治疗物质的复合物,每种生物活性基因治疗物质的复合物都是基于载体质粒,包含GPX3基因的cDNA部分,还包含与真核细胞(即人体器官和组织的细胞)结合或不结合转运分子的转录此序列的调控元件。本发明还涉及一种基于与氧化应激相关的GPX3基因生产用于纠正器官和组织和/或人体器官和组织的细胞的病理状况的试剂的方法。一种使用所述试剂基于与GPX3蛋白定量减少有关的GPX3基因校正器官和组织和/或人体器官和组织的细胞的病理状况的方法。效果:一组发明提供了一种高而稳定的方法细胞中靶蛋白的水平; 5 cl,18 ex,20 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号